X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
male (7) 7
female (6) 6
middle aged (6) 6
adult (5) 5
index medicus (5) 5
cancer (4) 4
treatment outcome (4) 4
adolescent (3) 3
aged (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
chemotherapy (3) 3
hematology (3) 3
lymphoma, large b-cell, diffuse - drug therapy (3) 3
oncology (3) 3
prednisone - administration & dosage (3) 3
prednisone - adverse effects (3) 3
aged, 80 and over (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
b cells (2) 2
bleomycin (2) 2
bleomycin - administration & dosage (2) 2
bleomycin - adverse effects (2) 2
care and treatment (2) 2
clinical trials (2) 2
cyclophosphamide - administration & dosage (2) 2
cyclophosphamide - adverse effects (2) 2
disease-free survival (2) 2
doxorubicin (2) 2
doxorubicin - administration & dosage (2) 2
doxorubicin - adverse effects (2) 2
elderly-patients (2) 2
follow-up studies (2) 2
hematology, oncology and palliative medicine (2) 2
hodgkin disease - drug therapy (2) 2
lymphoma, large b-cell, diffuse - mortality (2) 2
lymphomas (2) 2
non-hodgkins-lymphoma (2) 2
response criteria (2) 2
survival analysis (2) 2
young adult (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[ sdv.mhep.mi ] life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
[sdv.can] life sciences [q-bio]/cancer (1) 1
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
abridged index medicus (1) 1
acute lymphoblastic-leukemia (1) 1
adaptation au stress (1) 1
age (1) 1
aggressive lymphomas (1) 1
aids patient (1) 1
albumine (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
antibody (1) 1
antigens, cd - blood (1) 1
antineoplastic agents, immunological - administration & dosage (1) 1
antineoplastic agents, immunological - adverse effects (1) 1
antineoplastic agents, immunological - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antiviral agents - therapeutic use (1) 1
apnea (1) 1
apnea;biological stress markers;copeptin;cortisol;hypoxemia (1) 1
b-cell lymphoma (1) 1
b-cells (1) 1
bacteria (1) 1
biological stress markers (1) 1
brain natriuretic peptide (1) 1
burkholderia pseudomallei (1) 1
calcium-binding protein (1) 1
cancer patients (1) 1
cardiovascular conditions, disorders and treatments (1) 1
case studies (1) 1
castlemans-disease (1) 1
cavity-based lymphomas (1) 1
cd20 antigen (1) 1
cell survival (1) 1
clinical medicine (1) 1
clonality (1) 1
cold (1) 1
competition (1) 1
copeptin (1) 1
coronary artery disease (1) 1
cortisol (1) 1
cortisolémie (1) 1
cryoglobulinemia (1) 1
cryoglobulinemia - physiopathology (1) 1
cyclophosphamide (1) 1
cyclophosphamide - therapeutic use (1) 1
dehydrogenases (1) 1
demographic aspects (1) 1
des-lymphomes (1) 1
diagnosis (1) 1
disease (1) 1
disease survivors (1) 1
diving (1) 1
dna-sequences (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESPONSE CRITERIA | AGGRESSIVE LYMPHOMAS | POOR-PROGNOSIS | NON-HODGKINS-LYMPHOMA | REGIMEN | YOUNG-PATIENTS | ELDERLY-PATIENTS | DES-LYMPHOMES | TRANSPLANTATION | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 12, pp. 1160 - 1170
Summary Background Little is known about the longitudinal course of health-related quality of life (HRQoL) in patients with Hodgkin's lymphoma during their... 
Hematology, Oncology and Palliative Medicine | INSTRUMENT | LONG-TERM SURVIVORS | GENERAL-POPULATION | ONCOLOGY | FATIGUE | QLQ-C30 | DISEASE SURVIVORS | CANCER | Hodgkin Disease - psychology | Follow-Up Studies | Humans | Middle Aged | Adolescent | Hodgkin Disease - drug therapy | Quality of Life | Adult | Female | Male | Aged
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2017, Volume 4, Issue 1, pp. e46 - e55
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2015, Volume 90, Issue 3, pp. 197 - 203
Journal Article
Physiological Reports, 03/2019, Volume 7, Issue 6, pp. e14033 - n/a
This study investigated the sources of physiological stress in diving by comparing SCUBA dives (stressors: hydrostatic pressure, cold, and hyperoxia), apneic... 
copeptin | cortisol | hypoxemia | Apnea | SCUBA | biological stress markers | Myoglobin | Competition | Brain natriuretic peptide | Cold | Physical activity | Hormones | Hydrocortisone | Pressure | Coronary artery disease | Sleep disorders | Physical fitness | Troponin | Hypoxemia | Exercise | Ischemia | Calcium-binding protein | Hyperoxia | Hypoxia | Diving | Physiology | Lactic acid | Heart diseases | Age
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 04/2018, Volume 100, Issue 5, pp. 1133 - 1145
Journal Article
Cancer, ISSN 0008-543X, 09/1997, Volume 80, Issue 6, pp. 1124 - 1133
BACKGROUND To determine whether a high risk group could be identified within a group of patients with advanced stage Hodgkin's disease (HD), the authors... 
high dose chemotherapy | Lymph Node | prognostic factors | salvage therapy | Hodgkin's disease
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.